Please check your internet connection and try again.
## Sodium Phosphate Enema
### Overview
Sodium phosphate enema is a hypertonic saline solution used as a laxative and bowel cleansing agent. It works by drawing water into the colon, increasing bowel motility and softening stool.
### Primary Indications
* Bowel preparation for diagnostic procedures (e.g., colonoscopy, sigmoidoscopy).
* Short-term treatment of occasional constipation.
### Adult Dosing
* **Bowel Preparation:** Typically, one 4.5 fl oz (133 mL) bottle administered once. For optimal cleansing, may be repeated once after 8-10 hours if necessary, as per specific protocol.
* **Constipation:** One 2.25 fl oz (66 mL) bottle administered once.
### Pediatric Dosing
* **Children 2 to <12 years:** 1.125 fl oz (33 mL) to 2.25 fl oz (66 mL) once.
* **Children <2 years:** Use is not recommended due to increased risk of serious adverse events.
### Dose Adjustments
No specific dose adjustments are routinely recommended. However, caution and potentially reduced doses are advised in patients with renal impairment, heart failure, or those on sodium-restricted diets.
### Contraindications
* Congenital or acquired megacolon.
* Intestinal obstruction or perforation.
* Severe rectal inflammation or ulceration.
* Known hypersensitivity to sodium phosphate.
* Anuria.
* Children under 2 years of age.
* Patients with impaired renal function (e.g., moderate to severe chronic kidney disease) or those at risk for hyperphosphatemia, hypocalcemia, or hypernatremic dehydration.
### Adverse Effects
* **Common:** Abdominal cramping, nausea, vomiting, bloating, diarrhea, rectal irritation.
* **Serious:**
* **Electrolyte Disturbances:** Hyperphosphatemia, hypocalcemia, hypernatremia, dehydration. This can lead to tetany, seizures, cardiac arrhythmias, and acute kidney injury.
* **Renal Impairment:** Acute kidney injury, especially with repeated or high-dose use, or in patients with underlying renal disease.
* **Colonic Mucosal Changes:** Ulceration, necrosis, perforation (rare but serious).
### Key Drug Interactions
* **Diuretics:** Increased risk of dehydration and electrolyte imbalances.
* **ACE Inhibitors/ARBs:** Potential for increased risk of hyperkalemia and renal impairment.
* **Drugs affecting electrolyte balance (e.g., corticosteroids):** May exacerbate electrolyte disturbances.
* **Drugs that prolong QT interval:** Risk of additive effects on cardiac rhythm.
### Monitoring
* Electrolytes (phosphate, calcium, sodium, potassium), renal function (BUN, creatinine) before and after use, especially in at-risk patients.
* Hydration status.
* Signs of severe abdominal pain or rectal bleeding.
### Clinical Pearls
* **Hydration is critical:** Patients should be advised to drink plenty of clear fluids before, during, and after administration to prevent dehydration and electrolyte imbalances.
* **Avoid repeated doses:** Unless specifically instructed and closely monitored, avoid repeated administrations within a short period.
* **Patient education:** Emphasize proper administration technique and the importance of reporting any severe side effects.
* **Risk factors:** Be particularly cautious in elderly patients, those with pre-existing renal or cardiac conditions, and those on fluid or sodium restriction.
***
*Please verify current prescribing information with the manufacturer's official product insert and consult with a healthcare professional for specific patient management.*
